Better Therapeutics IncOver The Counter Market:BTTX
- LAST PRICE0.0000
- TODAY'S CHANGE (%)-0.0001 (-99.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0001
- Day Range
- 52 Week Range
- Volume1,588
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BTTX |
|---|---|---|
| 09:50 ET | 1588 | 1E-06 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Better Therapeutics Inc | 50.0 | 0.0x | --- |
Verde Science Inc | 20.0 | 0.0x | --- |
Rebus Holdings Inc | 30.0 | 0.0x | --- |
PZ Wind Down Inc | 10.0 | 0.0x | --- |
ContraFect Corp | 10.0 | 0.0x | --- |
Oncovista Innovative Therapies Inc | 2.4K | 0.0x | --- |
Company Information
Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company. The Company is engaged in developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases. Its lead PDT product candidate, BT-001, is an investigational prescription digital therapy for the treatment of T2D. The investigational therapy is delivered via software that provides a tailored experience to patients designed to help them address the underlying causes of T2D by making meaningful, sustainable behavioral changes. The BT-001 investigational therapy is rooted in the well-studied, gold standard of behavioral modification therapies, cognitive behavioral therapy (CBT). The Company's platform consists of three behavioral therapy, treatment plans and personalization. Its behavioral therapy consists of lessons, skill- building modules, and a mechanism for goal setting. Its treatment plan is the primary engagement interface for patients.
Contact Information
- Headquarters
- 548 Market St. #49404SAN FRANCISCO, CA, United States 94101
- Phone
- 415-887-2311
- Fax
- 714-978-2166
Executives
- President, Chief Executive Officer, Treasurer, Company Secretary, Director
- Craig Jalbert
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 49.9M |
Better Therapeutics Inc does not pay a dividend. | |
Beta | 1.58 |
EPS | $-1.16 |
Book Value | $-0.04 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
